SGN-40

dacetuzumab · Seagen Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SGN-40, covering 2014-03-20 to 2015-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma [Phase 2]